- Home
- / 3sbio
3sbio
Stock Price
$6.1
2024-10-29
Market Capitalization
$14.1 B
2024-10-29
Revenue
¥17.7 B
FY, 2025
3sbio Summary
Company Summary
- Overview
- 3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
- Type
- Public
- Status
- Active
- Founded
- 1993
- HQ
- Shenyang, CN | view all locations
- Website
- http://www.3sbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Shenyang, Liaoning HQ
China
No. 1A 3, No. 10 Road
3sbio Financials
Summary Financials
- Revenue (FY, 2025)
- ¥17.7B
- Gross profit (FY, 2025)
- ¥17.0B
- Net income (FY, 2025)
- ¥9.1B
- Cash (FY, 2025)
- ¥12.2B
- EBIT (FY, 2025)
- ¥10.4B
- Enterprise value
- $4.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026